Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Epizyme Inc. sell Lokrim

Start price
€2.63
11.12.21 / 20%
Target price
-
11.12.22
Performance (%)
-45.63%
End price
-
08.12.22
Summary
This prediction is currently being closed. The SELL prediction by Lokrim for Epizyme Inc. is performing very well with a performance of -45.63%. Lokrim has 20% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Epizyme Inc. - - -
iShares Core DAX® 2.149% 5.415% 21.385%
iShares Nasdaq 100 0.838% 1.926% 44.386%
iShares Nikkei 225® 1.143% 2.887% 27.641%
iShares S&P 500 1.265% 3.698% 33.327%

According to Lokrim what are the pros and cons of Epizyme Inc. for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment

Comments by Lokrim for this prediction

In the thread Epizyme Inc. diskutieren

Sell Epizyme Inc.

In the thread Trading Epizyme Inc.
Prediction Sell
Perf. (%) -45.63%
Target price
Change
Ends at 11.12.22

Sell beendet

Stopped prediction by Lokrim for Epizyme Inc.

Epizyme Inc.

Start price
Target price
Perf. (%)
€13.60
08.04.20
-
04.11.21
-68.53%
05.11.21

Probably not worthwhile Investment
Epizyme Inc.

Start price
Target price
Perf. (%)
€19.60
26.01.20
-
08.04.20
-29.08%
08.04.20

Probably not worthwhile Investment